Aizentx
San Diego, US · Founded 2023 · 1 known investors
Aizen is an AI-native biotechnology company that designs novel oral peptides using non-canonical amino acids and an AI platform called DaX to treat chronic immune disorders. The company develops both proprietary therapeutics and partners with biopharma companies to advance gut-restricted and systemic oral biologics.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
Aizentx was founded in 2023 by David Van Valen and Ajay Kshatriya.
DV

David Van ValenFounder, Caltech Professor
AK
Ajay KshatriyaMBA
BG

Bernhard GeierstangerPhD
TP

Todd PetersonPhD
Investors · 1
Competitors · 3
by search overlapBioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Clementia4 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
IQVIA4 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Companies competing with Aizentx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aizentx do?
- Aizen is an AI-native biotechnology company that designs novel oral peptides using non-canonical amino acids and an AI platform called DaX to treat chronic immune disorders. The company develops both proprietary therapeutics and partners with biopharma companies to advance gut-restricted and systemic oral biologics.
- Who founded Aizentx?
- Aizentx was founded by David Van Valen, Ajay Kshatriya in 2023.
- Who are Aizentx's investors?
- Aizentx's investors include Madrona Venture Group.
- Where is Aizentx headquartered?
- Aizentx is headquartered in San Diego, US.
